CervoMed
CRVO
9 hedge funds and large institutions have $774K invested in CervoMed in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 6 closing their positions.
86% more capital invested
Capital invested by funds: $417K → $774K (+$357K)
0% less ownership
Funds ownership: 0.08% → 0.08% (-0%)
18% less funds holding
Funds holding: 11 → 9 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$180K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$67.4K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.2K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$66K |
| 2 |
Two Sigma Investments
New York
|
-$64K |
| 3 |
VF
Virtu Financial
New York
|
-$37K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$26K |
| 5 |
Citigroup
New York
|
-$1K |
CRVO Hedge Fund Activity: Q1 2019 in Review
9 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2019, worth a combined $774K — up 86% from $417K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CRVO and 4 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $180K. The largest seller was Anson Funds Management, exiting entirely with an estimated $66K sold.
- 9 institutional investors held CervoMed (CRVO) as of Q1 2019, down from 11 in Q4 2018.
- Funds reported $774K of CervoMed stock for Q1 2019, up 86% quarter-over-quarter.
- 4 funds opened new CervoMed positions in Q1 2019 and 6 closed out, a net change of -2 holders.
- The largest CervoMed buyer in Q1 2019 was Renaissance Technologies, an estimated $180K added.
- The largest CervoMed seller in Q1 2019 was Anson Funds Management, an estimated $66K sold.
Based on aggregated 13F filings for Q1 2019.